Effectiveness and safety of niraparib as neoadjuvant therapy in advanced ovarian cancer with homologous recombination deficiency: NANT study protocol for a prospective, multicenter, exploratory, phase 2, single-arm study (041)
Year: 2022
Type: article
Source: Gynecologic Oncology
Authors: Yang Yu, Wei Zhang, Ronghua Liu, Wanying Shan, Huayi Li, Jiahao Liu, Bairong Xia, Shanyang He, Yu Xia, Siyuan Wang, Tian Fang, Zhi Wang, Rong Liu, Danhui Weng, Youguo Chen, Kun Song, Shuzhong Yao, Jundong Li, Li Wang, Qingshui Li, Jinjin Yu, Ding Ma, Li Hong, Yi Huang, Qinglei Gao
Institutions: Tongji Hospital, Huazhong University of Science and Technology, University of Science and Technology of China, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, First Affiliated Hospital of Soochow University, Shandong University, Qilu Hospital of Shandong University, The First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center, Zhengzhou University, Shandong Tumor Hospital, Wuxi Fourth People's Hospital, Renmin Hospital of Wuhan University, Hubei Cancer Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4297776359